Last Updated: April 28, 2024
whataboutmycml.com has 10 NS records, 2 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for whataboutmycml.com are a2-66.akam.net, a7-64.akam.net, dns2.novartis.com, a28-67.akam.net, a24-65.akam.net, dns1.novartis.com, dns4.novartis.com, dns3.novartis.com, a9-65.akam.net, a1-254.akam.net. A records for whataboutmycml.com are 104.18.37.120, 172.64.150.136. We have observed whataboutmycml.com to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint.
Search DigitalStakeout Footprint to find another asset.
104.18.37.120
172.64.150.136
No DNS AAAA records
No DNS MX records
a2-66.akam.net
a7-64.akam.net
dns2.novartis.com
a28-67.akam.net
a24-65.akam.net
dns1.novartis.com
dns4.novartis.com
dns3.novartis.com
a9-65.akam.net
a1-254.akam.net
No DNS TXT records
whataboutmycml.com has 2 subdomains in our inventory.
cloudflare
United States
{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1720915199, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "C3:06:FF:B3:8A:CF:10:81:C9:D0:86:8B:BE:5E:14:23:B9:B4:33:30", "authorityKeyIdentifier": "keyid:17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:www.whataboutmycml.com, DNS:www.vijoice.com, DNS:www.ustasigna.com, DNS:www.us.vijoice.com, DNS:www.us.jadenu.com, DNS:www.understanding-mbc.com, DNS:www.treatingcarcinoidsyndrome.com, DNS:www.tasigna-hcp.com, DNS:www.tafinlarmekinistcombo.com, DNS:www.tafinlarandmekinistcombo.com, DNS:www.tabrecta-hcp.com, DNS:www.start-tabrecta.com, DNS:www.sandostatinsupport.com, DNS:www.sandostatin-us.com, DNS:www.sandostatin-hcp-us.com, DNS:www.sandostatin-dosing.com, DNS:www.promacta.com, DNS:www.piqray-pricing.com, DNS:www.pik3ca-cdx.com, DNS:www.pik3ca-cdx-order.com, DNS:www.phenotypicprecisionmedicine.com, DNS:www.nsclcbiomarkers.com, DNS:www.mobilecarcinoidpatient.com, DNS:www.mobilecarcinoidhcp.com, DNS:www.medexpertlibrary.com, DNS:www.mbc-info.com, DNS:www.makingsandostatin.com, DNS:www.learnaboutpsma.com, DNS:www.kisqali-parami.com, DNS:www.ironoverload.com, DNS:www.how-piqray-works.com, DNS:www.hcp-tabrecta.com, DNS:www.gleevec.com, DNS:www.copayrequestform.com, DNS:www.cmlbasics.com, DNS:www.cml-treatment.com, DNS:www.brafv600e.com, DNS:www.advanced-breastcancer.com, DNS:www.Targetlungcancer.com, DNS:www.TargetedTrial.com, DNS:www.Target-mNSCLC.com, DNS:www.Sandostatin-training.com, DNS:www.Sandostatin-hcp.com, DNS:www.Sandostatin-administration.com, DNS:www.Sandostatin-access.com, DNS:www.NSCLCmutation.com, DNS:www.METinNSCLC.com, DNS:www.GetSickleCellHelp.com, DNS:www.Explore-Tabrecta.com, DNS:www.Discover-Tabrecta.com, DNS:www.ADAKVEO-NurseResources.com, DNS:www.ADAKVEO-HCP.com, DNS:ww.Rx-Tabrecta.com, DNS:whataboutmycml.com, DNS:vijoice.com, DNS:ustasigna.com, DNS:us.vijoice.com, DNS:us.jadenu.com, DNS:understanding-mbc.com, DNS:treatingcarcinoidsyndrome.com, DNS:tasigna-hcp.com, DNS:tafinlarmekinistcombo.com, DNS:tafinlarandmekinistcombo.com, DNS:tabrecta-hcp.com, DNS:start-tabrecta.com, DNS:sandostatinsupport.com, DNS:sandostatin-us.com, DNS:sandostatin-hcp-us.com, DNS:sandostatin-dosing.com, DNS:promacta.com, DNS:piqray-pricing.com, DNS:pik3ca-cdx.com, DNS:pik3ca-cdx-order.com, DNS:phenotypicprecisionmedicine.com, DNS:nsclcbiomarkers.com, DNS:mobilecarcinoidpatient.com, DNS:mobilecarcinoidhcp.com, DNS:medexpertlibrary.com, DNS:mbc-info.com, DNS:makingsandostatin.com, DNS:learnaboutpsma.com, DNS:kisqali-parami.com, DNS:ironoverload.com, DNS:how-piqray-works.com, DNS:hcp-tabrecta.com, DNS:gleevec.com, DNS:copayrequestform.com, DNS:cmlbasics.com, DNS:cml-treatment.com, DNS:brafv600e.com, DNS:advanced-breastcancer.com, DNS:Targetlungcancer.com, DNS:TargetedTrial.com, DNS:Target-mNSCLC.com, DNS:Sandostatin-training.com, DNS:Sandostatin-hcp.com, DNS:Sandostatin-administration.com, DNS:Sandostatin-access.com, DNS:Rx-Tabrecta.com, DNS:NSCLCmutation.com, DNS:METinNSCLC.com, DNS:GetSickleCellHelp.com, DNS:Explore-Tabrecta.com, DNS:Discover-Tabrecta.com, DNS:ADAKVEO-NurseResources.com, DNS:ADAKVEO-HCP.com, DNS:access.novartis.com", "crlDistributionPoints": "Full Name:\n URI:http://crl.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crl", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.2\nPolicy: 1.3.6.1.4.1.6449.1.2.1.3.4\n CPS: https://sectigo.com/CPS", "ctlSignedCertificateTimestamp": "BIIBaQFnAHYAdv-IPwq2-5VRwmHM9Ye6NLSkzbsp3GhCCp_mZ0xaOnQAAAGJUdM_9QAABAMARzBFAiEAnJThuIBQlZTRQrS1ycHP_6ROF7wcJc5F5JKwa3cjynUCIH8HXrMeLr25Pe2Z1nNLH4RIaJMflhU7KVkTwXkF6cv7AHUA2ra_az-1tiKfm8K7XGvocJFxbLtRhIU0vaQ9MEjX-6sAAAGJUdNATAAABAMARjBEAiAo1ntQiZVjq_vsFWVv8R-fAP72mvioc56jSYnGGq4kZQIgK2FjDAWdc16pHl4ah9DlZkh3sQJUhViGvrMeDuO50nIAdgDuzdBk1dsazsVct520zROiModGfLzs3sNRSFlGcR-1mwAAAYlR00ArAAAEAwBHMEUCIENy44gYgY9xRB6AZrpDaYi7-7WBgzsRWvhT7oyCMBJVAiEAgJrzg82P7_YGME62Gyxkc3UX08U-hehrXakPyAMp6q4=", "authorityInfoAccess": "OCSP - URI:http://ocsp.sectigo.com\nCA Issuers - URI:http://crt.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crt\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "83:94:55:B9:CC:8C:E3:1C:79:71:86:0A:CB:14:41:08:73:B7:41:9C", "all_domains": ["www.tabrecta-hcp.com", "www.sandostatin-hcp-us.com", "www.promacta.com", "sandostatin-us.com", "mobilecarcinoidhcp.com", "Explore-Tabrecta.com", "brafv600e.com", "Sandostatin-hcp.com", "www.brafv600e.com", "www.TargetedTrial.com", "www.Sandostatin-administration.com", "makingsandostatin.com", "www.Explore-Tabrecta.com", "www.pik3ca-cdx.com", "nsclcbiomarkers.com", "understanding-mbc.com", "tabrecta-hcp.com", "www.whataboutmycml.com", "www.sandostatinsupport.com", "www.mbc-info.com", "sandostatin-hcp-us.com", "www.learnaboutpsma.com", "TargetedTrial.com", "www.tasigna-hcp.com", "www.medexpertlibrary.com", "www.mobilecarcinoidpatient.com", "sandostatin-dosing.com", "mobilecarcinoidpatient.com", "us.vijoice.com", "Sandostatin-training.com", "sandostatinsupport.com", "www.ADAKVEO-NurseResources.com", "www.makingsandostatin.com", "www.hcp-tabrecta.com", "mbc-info.com", "www.how-piqray-works.com", "www.advanced-breastcancer.com", "www.NSCLCmutation.com", "www.sandostatin-dosing.com", "www.Target-mNSCLC.com", "Sandostatin-administration.com", "www.vijoice.com", "pik3ca-cdx.com", "Targetlungcancer.com", "ironoverload.com", "www.phenotypicprecisionmedicine.com", "cmlbasics.com", "treatingcarcinoidsyndrome.com", "www.us.vijoice.com", "how-piqray-works.com", "whataboutmycml.com", "vijoice.com", "Target-mNSCLC.com", "www.Targetlungcancer.com", "ADAKVEO-NurseResources.com", "ww.Rx-Tabrecta.com", "NSCLCmutation.com", "tafinlarmekinistcombo.com", "ustasigna.com", "www.nsclcbiomarkers.com", "gleevec.com", "us.jadenu.com", "www.mobilecarcinoidhcp.com", "tafinlarandmekinistcombo.com", "www.piqray-pricing.com", "www.ustasigna.com", "www.Sandostatin-training.com", "www.kisqali-parami.com", "www.sandostatin-us.com", "METinNSCLC.com", "www.GetSickleCellHelp.com", "www.cmlbasics.com", "GetSickleCellHelp.com", "medexpertlibrary.com", "www.METinNSCLC.com", "kisqali-parami.com", "phenotypicprecisionmedicine.com", "www.copayrequestform.com", "learnaboutpsma.com", "copayrequestform.com", "www.tafinlarandmekinistcombo.com", "www.gleevec.com", "www.ADAKVEO-HCP.com", "Rx-Tabrecta.com", "Discover-Tabrecta.com", "ADAKVEO-HCP.com", "www.treatingcarcinoidsyndrome.com", "cml-treatment.com", "www.pik3ca-cdx-order.com", "www.ironoverload.com", "www.us.jadenu.com", "www.Sandostatin-access.com", "hcp-tabrecta.com", "www.cml-treatment.com", "piqray-pricing.com", "www.Sandostatin-hcp.com", "access.novartis.com", "advanced-breastcancer.com", "www.Discover-Tabrecta.com", "www.start-tabrecta.com", "www.understanding-mbc.com", "tasigna-hcp.com", "Sandostatin-access.com", "start-tabrecta.com", "promacta.com", "pik3ca-cdx-order.com", "www.tafinlarmekinistcombo.com"], "serial_number": "9641DFA850DAAA711767D5AE14F8A018", "subject": {"C": "US", "CN": "access.novartis.com", "L": null, "O": "Novartis Pharmaceuticals Corporation", "ST": "New Jersey", "emailAddress": null, "OU": null, "aggregated": "/C=US/CN=access.novartis.com/O=Novartis Pharmaceuticals Corporation/ST=New Jersey"}, "not_before": 1689292800, "issuer": {"C": "GB", "CN": "Sectigo RSA Organization Validation Secure Server CA", "L": "Salford", "O": "Sectigo Limited", "ST": "Greater Manchester", "emailAddress": null, "OU": null, "aggregated": "/C=GB/CN=Sectigo RSA Organization Validation Secure Server CA/L=Salford/O=Sectigo Limited/ST=Greater Manchester"}}, "cert_link": "https://ct.googleapis.com/logs/us1/argon2024/ct/v1/get-entries?start=145920646&end=145920646", "source": {"url": "https://ct.googleapis.com/logs/us1/argon2024/", "name": "Google 'Argon2024' log"}, "update_type": "X509LogEntry", "seen": 1690986291.375535, "cert_index": 145920646}}